Key measured outcomes in that trial format include: percent change in body weight over the protocol window waist circumference and other anthropometric measures adverse events and discontinuations These are the exact measurements that make the literature readable and non vague
These effects may potentially provide a novel therapeutic solution for stroke, imparting specific beneficial effects on the CNS (i.e., for reperfusion, the amelioration of neuronal damage and, thereby, recovery without memory, locomotor, and coordination disturbances, and the expression of the particular genes in the hippocampus)
Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance
Persistent symptoms beyond 10 days or severe pain with fever requires immediate medical evaluation to prevent complications
JP patent 60,160,894 Acknowledgements The authors thank Dr